Robert A Lookstein MD, MHCDL

I ask my professional contacts and colleagues to follow this model. Please block all anonymous accounts. The tone of these accounts has become increasing aggressive and harmful. They do not deserve your attention. If you follow, you are endorsing this behavior on #medtwitter

Funding Opportunity for Early-Career Scientists The VIVA Foundation, in partnership with the American Heart Association, is proud to provide funding opportunities that support early-career scientists pursuing careers in vascular science. The American Heart Association Postdoctoral Fellowship provides a one- or two-year stipend for postdoctoral researchers working within a team environment under the guidance of an experienced research mentor. Eligible applicants must hold a doctoral-level degree (MD, DO, DVM, PharmD, DDS, DPh, PhD, or equivalent in science, nursing, public health, or another clinical health science field). 📅 Applications are due August 5, 2026, at 3:00 PM CT Learn More - professional.heart.org/en/research-pr…

Late-Breaking Clinical Trial submissions close THIS THURSDAY, July 9. Have new clinical data that deserves the spotlight? Submit your Late-Breaking Clinical Trial for the opportunity to present at VIVA & The VEINS 2026 before a multidisciplinary audience of vascular specialists. Don't miss your chance to share research that could shape the future of vascular care. Deadline: Thursday, July 9 Submit today: viva-foundation.org/clinical-trials

The VIVA Foundation is pleased to announce the appointment of Robert A. Lookstein to the Board of Directors. We are delighted to welcome Dr. Lookstein’s leadership, insight, and expertise to the Foundation. His extensive experience in interventional radiology, commitment to multidisciplinary care, and longstanding contributions to clinical research and innovation will strengthen our work as we continue to expand impact across the vascular disease community. We look forward to his contributions as a member of the Board and are honored to have him join us in shaping the future of VIVA. Congratulations, @roblookstein!

Congratulations to Dr. Robert A. Lookstein on his appointment to the @VIVAPhysicians Board of Directors! We’re proud to celebrate this well-deserved honor and his continued leadership in interventional radiology. 👏🏻 @roblookstein viva-foundation.org/news-article?i…

Aidoc Receives FDA Breakthrough Device Designation for AI That Drafts Radiology Reports aidoc.com/?p=14905

Live @MountSinaiIR @IcahnMountSinai @bonesz wins the Harold Mitty Award for excellence in teaching in Interventional Radiology. Well deserved. Congratulations

Live @SIRspecialists Publication Alert!!! The 2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN Guideline for the Evaluation and Management of Acute Pulmonary Embolism in Adults: Pertinent Points for the Interventional Radiologist jvir.org/article/S1051-…

Live @MountSinaiIR @DOMSinaiNYC @MountSinaiNYC Publication Alert !!! Association of advanced therapy with improved RV function for Acute PE. frontiersin.org/journals/cardi…

Live @PERTConsortium Publication Alert!!! The largest registry report on Acute Pulm Emb ever Pulmonary Embolism in the United States: A Report From the National PERT Consortium - Journal of the Society for Cardiovascular Angiography & Interventions jscai.org/article/S2772-…

What does it really take to run a high-volume Y-90 program that is efficient, scalable, and patient-centered? In this episode of BackTable 2026 HCC Creator Weekend™, host Dr. Zach Berman is joined by Drs. Nima Kokabi and @kiremagarciamd to break down the systems, workflows, and strategies that drive successful radioembolization centers. 🎧Tune into the full episode on the BackTable App: na2.hubs.ly/H05VKjq0 This podcast is supported by an educational grant from Sirtex and Boston Scientific. #VI651 #InterventionalRadiology #IRad #VIR #HepatocellularCarcinoma #HCC #Y90 #Radioembolization #MedEd #BackTable @UNC_Health_Care @MountSinaiNYC

Live @SIRspecialists another pivotal trial result presented at #SIRT0R26 demonstrating the continued growth of deep venous interventions. venousnews.com/gore-viabahn-f…

Live #GEST2026 always great to get an impromptu strategic catch up between @SIRspecialists #Prez @saherssabri and yours truly as immediate #PastPrez

Examining the applications of embolization, a group from @IcahnMountSinai details how excellence can be achieved across diverse applications, underscoring the importance of technique refinement, cross-specialty collaboration, & procedural standardization. evtoday.com/articles/2026-…

Live @MountSinaiIR #GEST2026 #MeettheExperts with no other than @bonesz sharing tips for tackling complex #PAE cases @SIRspecialists

Live @MountSinaiIR our very own @RSP516 wins abstract of the year at #GEST2026 for his work as National PI for the OCCLUDE registry. 🙌👏

#SIRTOR26 incredible memories...proud to serve @SIRspecialists and appreciate what we have accomplished as a team of dedicated volunteers and inspiring professional staff. Already looking forward to #SIRLA27

Live @MountSinaiIR innovation is what distinguishes our group, providing creative solutions for our patients. @DanShilo is leading our #MSK embolization program @MountSinaiNYC mountsinai.org/about/patient-…

Live @MountSinaiIR Publication Alert!! Incredible effort to set the standard for #LRT for #HCC Consortium on Bridging Radiation Segmentectomy (COBRAS): A Multicenter Study of Complete Pathologic Necrosis in Hepatocellular Carcinoma | Radiology pubs.rsna.org/doi/10.1148/ra…

Live @MountSinaiIR we are proud to share we performed 56 outpt embolizations for UFE,PAE,GAE, and HAE at our Embolization Center of Excellence @MountSinaiNYC WestCampus in April. This is a testament to our MDs, nurses, technologists, office staff, and our patients. TYSM!!

Live @SIRspecialists Is It Time to Rethink PE Treatment? Functional Outcomes From STORM‑PE physiciansweekly.com/post/is-it-tim…